The CHEK2 1100delC variant in Swedish colorectal cancer

Anticancer Research

Volumn 26, Issue 6 C, 2006, Pages 4885-4888

  Djureinovic, Tatjana ^a   Lindblom, Annika ^a,d   Dalén, Johan ^b   Dedorson, Stefan ^c   Edler, David ^d   Hjern, Fredrik ^a   Holm, Jörn ^e   Lenander, Claes ^f   Lindforss, Ulrik ^d   Lundqvist, Nils ^g   Olivecrona, Hans ^h   Olsson, Louise ^a   Påhlman, Lars ⁱ   Rutegård, Jörgen ^j   Smedh, Kennet ^k   Törnqvist, Anders ^l   Eiberg, Hans ^m   Bisgaard, Marie Luise ^m  

^a DANDERYD HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

^c Södertälje University   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e GÄVLE HOSPITAL   (Sweden)

^f ERSTA HOSPITAL   (Sweden)

^g NORRTÄLJE HOSPITAL   (Sweden)

^h STOCKHOLM SÖDER HOSPITAL   (Sweden)

ⁱ UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^j ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^k CENTRAL HOSPITAL   (Sweden)

^l CENTRAL HOSPITAL   (Sweden)

^m UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

CHEK2; Colorectal cancer

Indexed keywords

CHECKPOINT KINASE 2;

ARTICLE; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC LINKAGE; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWEDEN;

EID: 33845938336     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A and Hemminki K: Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med 343: 78-85, 2000 .
2. de la Chapelle A: Genetic predisposition to colorectal cancer. Nat Rev Cancer 4: 769-780, 2004.
3. Bartek J, Falck J and Lukas J: CHK2 kinase - a busy messenger. Nat Rev Mol Cell Biol 2: 877-886, 2001.
4. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N and Stratton MR: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31: 55-59, 2002.
5. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP and Nevanlinna H: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71: 432-438, 2002.
6. Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R, de Snoo A, Fat GT, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A, Chapman P, Tops C, Moslem G, Burn J, Lynch H, Klijn J, Fodde R and Schutte M: The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72: 1308-1314, 2003.
7. Djureinovic T, Skoglund J, Vandrovcova J, Zhou XL, Kalushkova A, Iselius L and Lindblom A: A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. Gut 55: 362-366, 2006.
8. Liu T, Wahlberg S, Burek E, Lindblom P, Rubio C and Lindblom A: Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer 27: 17-25, 2000.
9. Wahlberg S, Liu T, Lindblom P and Lindblom A: Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test 3: 259-264, 1999.
10. CHEK2 Breast Cancer Case-Control Consortium: CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74: 1175-1182, 2004.
11. Isinger A, Bhat M, Borg A and Nilbert M: CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum. BMC Cancer 6: 64, 2006.
12. de Jong MM, Nolte IM, Te Meerman GJ, van der Graaf WT, Mulder MJ, van der Steege G, Bruinenberg M, Schaapveld M, Niessen RC, Berends MJ, Sijmons RH, Hofstra RM, de Vries EG and Kleibeuker JH: Colorectal cancer and the CHEK2 1100delC mutation. Genes Chromosomes Cancer 43: 377-382, 2005.
13. Kilpivaara O, Laiho P, Aaltonen LA and Nevanlinna H: CHEK2 1100delC and colorectal cancer. J Med Genet 40: e110, 2003.
14. Lipton L, Fleischmann C, Sieber OM, Thomas HJ, Hodgson SV, Tomlinson IP and Houlston RS: Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma. Cancer Lett 200: 149-152, 2003.